吸入给药技术在呼吸系统给药领域的研究与产业化 Research and industrialization of inhalation drug technology in the field of respiratory system administration
“瑞思普利”是一家专注于呼吸系统吸入给药配方技术及装置研发、生产、销售为一体的综合性企业，公司实际经营地址为：珠海市金湾区康德莱国际医疗产业园C幢一楼e区及珠海市金湾区国际健康港2号厂房3、4层，公司拥有650平米的研发办公环境以及5400平米的GMP生产车间；公司的吸入粉雾剂研发平台涵盖了呼吸系统全系列产品：涉及哮喘（Asthma）、慢性阻塞性肺病（COPD）、肺纤维化、抗病毒、偏头疼、糖尿病、帕金森等多个临床需求大的治疗领域，旨在开发未满足临床需求的产品。公司目标是成为吸入制剂领域药物研发和生产的领军企业。 “瑞思普利”始终秉承责任在先的理念，以创新、品质和技术服务，为全球饱受呼吸疾病困扰的人们改善生活、提高生存质量，为人类的健康事业贡献力量。 "Resproly" is a comprehensive enterprise specializing in respiratory inhalation delivery formulation technology and device research, production and sales. The actual business address of the company is: area e, first floor, Building C, Kangdelai International Medical Industrial Park, Jinwan District, Zhuhai City, and the 3rd and 4th floors of Building 2, International Health Port, Jinwan District, Zhuhai. The company has 650square meters of R & D office environment and 5400 square meters of GMP production workshop. The company's inhaled powder research and development platform covers a full range of respiratory products: asthma (Asthma), chronic obstructive pulmonary disease ((COPD)), pulmonary fibrosis, antiviral, migraine, diabetes, Parkinson's and other clinical treatment areas, aimed at developing products that do not meet clinical needs. The company's goal is to become a leader in drug R & D and production in the field of inhaled preparations. "Resproly" has always adhered to the concept of responsibility, innovation, quality and technical services to improve the lives of people suffering from respiratory diseases around the world, improve the quality of life, and contribute to the cause of human health.